Ads
related to: multiple sclerosis treatment
Search results
9 celebrities with multiple sclerosis who have opened up about the disease
Yahoo Canada Style· 4 hours ago“I knew nothing about the disease, to be honest. I fortunately had a doctor who told me right away...
Colorado hospitals detect 3 cases of infections linked to stem-cell treatments received in Mexico
Denver Post· 8 hours agoThe first case was reported in late 2022, in a woman who had embryonic stem-cell treatment in...
Immunic advances ‘potentially groundbreaking’ MS therapy vidofludimus calcium during Q1
Proactive Investors· 3 days agoImmunic Inc (NASDAQ:IMUX) continued to advance its clinical programs for its lead drug asset,...
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 hours agoRoyalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Royalty Pharma plc...
Diagnosing Multiple Sclerosis: 5 Things to Know
Medscape· 2 days agoIn the United States, nearly 1 million people are living with multiple sclerosis (MS), an immune-mediated inflammatory disease that causes demyelination...
Drug resistant infections reported after stem cell treatments in Mexico
Becker’s Hospital Review· 15 hours agoThe report describes three patients who acquired the infections during stem cell injections at two clinics in the Mexican border state of Baja California. It is not clear what caused the outbreak ...
UC San Francisco Scientists Find Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms...
Sierra Sun Times· 4 days agoMay 6, 2024 - By Levi Gadye - In a discovery that could hasten treatment for patients with multiple ...
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
GuruFocus.com via Yahoo Finance· 2 hours agoNotable among these is the FDA's recent approval of Fanapt for the treatment of acute bipolar I...
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 hour agoNektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...
Clene (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlights
Digital Journal· 1 day agoClene Nanomedicine is a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases. Highlights of the report include ...